Trials / Conditions / Primary Biliary Cholangitis (PBC)

Primary Biliary Cholangitis (PBC)

21 registered clinical trials studyying Primary Biliary Cholangitis (PBC) — 13 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Biochemical Response and Clinical Outcomes in Patients With PBC NCT07449793	RenJi Hospital	—
Recruiting	FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy NCT07296458	Xijing Hospital of Digestive Diseases	Phase 3
Recruiting	Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies ( NCT07205874	Hospital Universitario La Paz	—
Recruiting	PBC Long-term Outcomes Study NCT07149675	Beijing Friendship Hospital	—
Recruiting	Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC) NCT07104201	Xijing Hospital of Digestive Diseases	EARLY_Phase 1
Recruiting	EMPower Mechanisms NCT06861465	University of Alberta	N/A
Recruiting	RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis NCT07161245	Hospital Clinic of Barcelona	N/A
Enrolling By Invitation	A Multicenter, Randomized, Controlled Trial of Prednisone Combined With Ursodeoxycholic Acid in the Treatment NCT06591468	Han Ying	Phase 2 / Phase 3
Completed	Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 NCT06798454	Parvus Therapeutics, Inc.	Phase 1
Completed	A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Chol NCT06591455	Han Ying	EARLY_Phase 1
Active Not Recruiting	PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobilia NCT06604923	University of Aarhus	—
Recruiting	Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study NCT06755541	Xijing Hospital of Digestive Diseases	Phase 3
Recruiting	Fenofibrate in Primary Biliary Cholangitis: a Real World Study NCT06755151	Xijing Hospital of Digestive Diseases	Phase 3
Recruiting	A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis NCT06016842	Ipsen	Phase 3
Active Not Recruiting	CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) NCT05896124	Cascade Pharmaceuticals, Inc	Phase 2
Recruiting	A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Bi NCT07304843	Umecrine Cognition AB	Phase 1 / Phase 2
Unknown	Probiotics in PBC Patients of Poor Response to UDCA NCT03521297	Sun Yat-sen University	Phase 2
Completed	Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) NCT04047160	Kiminori Kimura, MD	Phase 1
Completed	Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic A NCT03188146	Humanity and Health Research Centre	—
Completed	Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) an NCT03124108	Genfit	Phase 2
Recruiting	Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai) NCT06767605	Asociación Española para el Estudio del Hígado	—